About Visiox Pharma
Visiox Pharma is a company based in Tarrytown (United States) founded in 2021 by Zachry Rome. Visiox Pharma has raised $7 million across 1 funding round from investors including Founding Partners. Visiox Pharma operates in a competitive market with competitors including Qlaris Bio, TearClear, 4B Technologies, Mannin Research and Aria Pharmaceuticals, among others.
- Headquarter Tarrytown, United States
- Founders Zachry Rome
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Visiox Pharmaceuticals, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7 M (USD)
in 1 rounds
-
Latest Funding Round
$7 M (USD), Seed
Aug 03, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Visiox Pharma
Visiox Pharma has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Seed round of $7 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Visiox Pharma
Visiox Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Founding Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delivers expert business consulting services to support organizational growth and strategy.
|
Locked | Locked | Locked |
Investor details for Visiox Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Visiox Pharma
Investment portfolio details for Visiox Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Visiox Pharma
Detailed financials for Visiox Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Visiox Pharma Comparisons
Peer comparison for Visiox Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Visiox Pharma
Visiox Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qlaris Bio, TearClear, 4B Technologies, Mannin Research and Aria Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based technology is developed for treating ophthalmic diseases.
|
|
| Locked | Locked | Locked |
Filter technology for preservative-free ophthalmic drugs is developed.
|
|
| Locked | Locked | Locked |
Drugs for neurological disorders including ALS and Alzheimer's are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for vascular diseases are developed by Mannin Research.
|
|
| Locked | Locked | Locked |
Develops innovative drug technologies for multiple diseases.
|
Detailed competitors of Visiox Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Visiox Pharma
Complete news archive for Visiox Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Visiox Pharma
Visiox Pharma was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Visiox Pharma is headquartered in Tarrytown, United States. It is registered at Tarrytown, New York, United States.
Ryan Bleeks is the current CEO of Visiox Pharma.
Visiox Pharma is a funded company, having raised a total of $7M across 1 funding round to date.
Visiox Pharma was founded in 2021 and is based in Tarrytown, United States. Focus is placed on the development of therapeutics targeting ophthalmic conditions. Drug candidates such as PDP-716, a brimonidine formulation for ocular hypertension and open-angle glaucoma, and SDN-037, a topical difluprednate used for post-surgical inflammation and pain, are advanced by the company in the pharmaceutical sector. Operations center on innovative treatments for eye-related disorders.
Visiox Pharma's top competitors include Qlaris Bio, 4B Technologies and TearClear.
Visiox Pharma has 1 investor. Key investors include Founding Partners.